Endometrial cancer classification: Difference between revisions

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer classification On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer classification
CDC on Endometrial cancer classification
Endometrial cancer classification in the news
Blogs on Endometrial cancer classification
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer classification

VisualWikitext

Latest revision as of 18:41, 26 November 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]

Overview

Endometrial cancer may be classified according to histology into either type I comprising 80% of endometrial cancers or type II accounting for around 20%.

Classification

Endometrial cancer may be classified according to histology into 2 types:^[1]

Type	Histology	Prognosis	Pathogenesis	Prevalence
Type I	Endometroid (adenocarcinoma)	Favorable (estrogen-responsive)	• May arise from atypical hyperplasia • Linked to unopposed estrogen stimulation	80%
Type II	• Endometroid • Serous • Clear cell • Mucinous • Squamous • Mesonephric • Undifferentiated	Typically bad prognosis	• Develops from atrophic endometrium • Not linked to hormonally driven pathogenesis	15-20%

References

↑ Bokhman JV (1983). "Two pathogenetic types of endometrial carcinoma". Gynecol Oncol. 15 (1): 10–7. PMID 6822361.

Template:WikiDoc Sources

[pmid6822361-1] Bokhman JV (1983). "Two pathogenetic types of endometrial carcinoma". Gynecol Oncol. 15 (1): 10–7. PMID 6822361.

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Endometrial cancer}}
-{{CMG}}{{AE}}{{MD}}
+{{CMG}}{{AE}}{{RAK}}
 ==Overview==
@@ Line 7: / Line 7: @@
 ==Classification==
-Endometrial cancer may be classified according to histology into 2 types:
+Endometrial cancer may be classified according to histology into 2 types:<ref name="pmid6822361">{{cite journal| author=Bokhman JV| title=Two pathogenetic types of endometrial carcinoma. | journal=Gynecol Oncol | year= 1983 | volume= 15 | issue= 1 | pages= 10-7 | pmid=6822361 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6822361  }} </ref>
-* Type I
-**
-* Type II
 {| class="wikitable"
 ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Type
@@ Line 22: / Line 18: @@
 | style="background:#F5F5F5;" align="center" + |Endometroid (adenocarcinoma)
 | style="background:#F5F5F5;" align="center" + |Favorable (estrogen-responsive)
-| style="background:#F5F5F5;" align="center" + |*May arise from atypical hyperplasia// *Linked to unopposed estrogen stimulation
+| style="background:#F5F5F5;" align="left" + |• May arise from atypical hyperplasia <br> • Linked to unopposed estrogen stimulation
 | style="background:#F5F5F5;" align="center" + |80%
 |-
 | style="background:#DCDCDC;" align="center" + |Type II
-| style="background:#F5F5F5;" align="center" + |*Endometroid *Serous *Clear cell *Mucinous *Squamous *Mesonephric *Undifferentiated
+| style="background:#F5F5F5;" align="left" + |• Endometroid <br>• Serous <br>• Clear cell <br>• Mucinous <br>• Squamous <br>• Mesonephric <br>• Undifferentiated
 | style="background:#F5F5F5;" align="center" + |Typically bad prognosis
-| style="background:#F5F5F5;" align="center" + |*Develops from atrophic endometrium </br> *Not linked to hormonally driven pathogenesis
+| style="background:#F5F5F5;" align="left" + |• Develops from atrophic endometrium <br>• Not linked to hormonally driven pathogenesis
 | style="background:#F5F5F5;" align="center" + |15-20%
 |}
-===Classification Based on Pathogenesis===
-* Endometrial cancers are classified into either type 1 or type 2:<ref>{{Cite web | title = endometrial cancer classification | url =http://www.cancer.gov/types/uterine/hp/endometrial-treatment-pdq#section/_9 }}</ref>
-:* Type 1 may arise from complex atypical [[hyperplasia]] and is pathogenetically linked to unopposed estrogenic stimulation.
-:* Type 2 develops from atrophic [[endometrium]] and is not linked to hormonally driven pathogenesis.
-===Classification Based on Histopathological Subtype===
-There are 7 subtypes of endometrial cancer based on histopathology:
-: 1. Endometrioid (75%–80%)(The most common endometrial cancer cell type is endometrioid adenocarcinoma, which is composed of malignant [[glandular]] epithelial elements)
-::* Ciliated adenocarcinoma
-::* Secretory adenocarcinoma
-::* [[Papillary]] or villoglandular
-::* Adenocarcinoma with squamous differentiation
-:::* Adenoacanthoma
-:::* Adenosquamous (Adenosquamous tumors contain malignant elements of both glandular and squamous epithelium)
-: 2. Uterine papillary serous (<10%)
-: 3. Mucinous (1%)
-: 4. Clear cell (4%)
-: 5. [[Squamous cell]] (<1%)
-: 6. Mixed (10%)
-: 7. Undifferentiated
 ==References==

Endometrial cancer classification: Difference between revisions

Latest revision as of 18:41, 26 November 2018

Overview

Classification

References

Navigation menu